KRAS and lung adenocarcinoma: The analysis confirmed the importance of the RAS-RAF-MEK-ERK pathway, but also identified RAP1GDS1 and RHOA as a synthetic lethal gene pair that—when knocked down—specifically impaired the proliferation and tumorigenicity of mutant KRAS lung adenocarcinoma cells, while having minimal effect on wildtype KRAS cells.